Balyasny Asset Management
ATYR

Balyasny Asset Management’s aTyr Pharma ATYR Stock Holding History

Balyasny Asset Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-227,142
Closed -$686K – 2574
2025
Q1 		$686K Buy
227,142
+182,832
+413% +$552K ﹤0.01% 1479
2024
Q4 		$160K Buy
+44,310
New +$160K ﹤0.01% 1769